Page 5 - Oxford Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DGAP-News: Scenic Biotech BV: Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman Scenic Biotech BV: Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman 02.02.2021 / 09:30 PRESS RELEASE - Dr. Philippe Dro brings entrepreneurial expertise and biotech, medtech and pharma industry experience - Successful serial entrepreneur with track record of growing companies, notably for Themis and Glycovaxyn - Joins at a key juncture in Scenic Biotech's strategic growth, building its pipeline of genetic modifier drug candidates Amsterdam, The Netherlands, 2 February, 2021 - Sceni...

Philippe Dro brings entrepreneurial expertise and biotech, medtech and pharma industry experience Successful serial entrepreneur with track record of growing companies, notably for Themis and GlycoVaxyn Joins at a key juncture in Scenic Biotech’s strategic growth, building its pipeline of genetic modifier drug candidates AMSTERDAM, The Netherlands, February 02, 2021 / B3C newswire / --Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, today a...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Vaccitech Doses First Patient in HBV002, a Phase 1b/2a Clinical Trial of VTP-300 ... Vaccitech LimitedFebruary 1, 2021 GMT OXFORD, United Kingdom, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient in HBV002. HBV002 is a Phase 1b/2a clinical trial designed to evalu...

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.